← Back to headlines
Merck Reports Positive Phase 3 Data for RSV Vaccine ENFLONSIA
Merck announced positive results from its phase 3 second-season RSV data for the vaccine ENFLONSIA, indicating continued efficacy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
NGO Provides Health Insurance for Pregnant Women in Enugu
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
Kwara State Government Pledges Improved Immunisation Efforts
just now